V
Voy
Aims to improve the daily lives of men by encouraging men to take control of their happiness and health and talk openly
About Voy
Voy (formerly Manual.co) offers a comprehensive weight loss program that integrates personalised coaching and medication to help individuals achieve sustainable weight loss. The program is designed for those who have struggled with traditional diet and exercise methods, providing a tailored approach that addresses both physical and emotional aspects of eating. Clients begin their journey with an online assessment to determine the most suitable treatment plan, followed by discreet delivery of prescribed medication and regular coaching sessions to track progress and reshape habits. The business primarily serves individuals seeking long-term weight management solutions, leveraging a subscription-based model to generate revenue. By focusing on personalized care and continuous support, Voy aims to enhance client outcomes, with participants reportedly losing five times more weight compared to diet and exercise alone. The program also addresses emotional eating, offering strategies to manage it effectively.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- London, United Kingdom
- Employees
- 360
- Open positions
- 61
- Dealroom signal
- 61.4/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Weight Management, Health and Wellness, Metabolism, Direct-to-Consumer, Sustainable Development Goals, Mentech, Tech for Patients, Hard Tech, Longevity, Digital Care
- Client focus
- b2c
- Investment activity
- 2 companies, latest Dec 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Latest news
Press, funding announcements and product moves mentioning Voy.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ANGELOther financing | Sep 2025 | — | — | James Smith | ↗ |
| EARLY VCOther financing | Sep 2024 | $39M | $154M | Octopus Ventures · Felix Capital · Cherry Ventures · FJ Labs | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Voy is 890K monthly website visits, up 53.4% over the last three months. Voy's team declined 38.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MoreLifeUnited KingdomDeliver a range of tailor-made health improvement programmes
→
Formel SkinBerlin, GermanyOffering a clear path to a clean skin
$132Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Felix Capital
Cherry Ventures
Cassius
Waldencast Ventures
James Smith
Series A6 investors entered at this stage
- SBSonoma Brands
FJ Labs
Acurio Ventures
Synetro Group
Octopus Ventures
Singular
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Voy on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Voy’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.